🇬🇧#AZN #отчетность

markettwits (@markettwits), Oct 30, 2026, 07:09 UTC

🇬🇧#AZN #отчетность AstraZeneca Q3 2026 Earnings - Core EPS: $2.79 (est $2.62) - Revenue: $16.21B (est $15.98B) - Core Operating Margin: 36% (est 33.6%) - Reconfirms Revenue And Core EPS Guidance

The excerpt is quoted from a public Telegram channel, which owns its text.

Read the original post on Telegram

More posts from markettwits · All channels